Date: 12 December
Location: India Expo Centre
The Indian pharma industry is expected to grow over 15 per cent per annum between 2015 and 2020 and is expected to outperform the global pharma industry, as per reports from India Brand Equity Foundation (IBEF). With the Government of India’s vision of making India the next major hub for end-to-end drug discovery, it is imperative that the indian pharmaceutical industry works cohesively towards achieving this vision.
With this overarching theme of Ideate. Innovate. Integrate. UBM India is pleased to present the Pharma Connect Congress taking place on 12 December 2018 at India Expo Centre, Greater Noida, Delhi NCR.
The key topics that will be discussed at the forum will include, but are not limited to the regulatory landscape of Indian pharmaceutical industry, strategies and plans to propel the industry towards the next level of growth, developing India’s potential as an R&D hub, addressing the talent gaps in the industry and strengthening the culture of quality in organizations.
“Got updated with current trends, information and discussion that took place at the conference was good. Networking product showcase was informative for new vendor development.”
Yogendra M Bhatt, CEO, Aggreem International
“The Pre-Connect Congress is a good platform for networking and discussion.”
Dhananjay Babar, Abbott Healthcare pvt ltd
“The discussions were very relavant and current. Everyone was very candid on what’s happening and what needs to happen”
Sireesha Yadlapalli, Senior Director, Strategic Marketing, USP